MK

Manickam Kannan

Active Director Director DIN 08488039
DIN 08488039 First appointment Jun 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Manickam Kannan

Data last updated:

Manickam Kannan is a Director at Real Cure Pharmaceuticals Private Limited (since 2019). The company operates in Pharma.

DIN 08488039
Primary Designation Director
Industry Pharma
First Appointment 20 Jun 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Jun 20192019Active

Board colleagues of Manickam Kannan

NameDINCompanyDesignation
Poornima Kannan08488040Real Cure Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Real Cure Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manickam Kannan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manickam Kannan

Manickam Kannan currently holds 1 directorship: Real Cure Pharmaceuticals Private Limited (Director, since 20 Jun 2019).

Manickam Kannan was first appointed on 20 Jun 2019 as Director at Real Cure Pharmaceuticals Private Limited.

The current boards of Manickam Kannan's companies include Poornima Kannan (Real Cure Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available